Roger Bate | 01 Dec 2005 | TCS Daily
In the urgency of scaling up much needed treatment for people living with HIV/AIDS, setting targets is a natural and central prescription; however targets are political tools and should be used with extreme caution by international technical bureaucracies.
Richard Tren & Philip Coticelli | 09 Nov 2005 | Mail & Guardian
Richard Tren and Philip Coticelli discuss the history of DDT and argue for its regulated use in malaria control.
Richard Tren & Philip Coticelli | 08 Nov 2005 | Business Day (South Africa)
Richard Tren and Philip Coticelli argue that donors should support DDT for malaria control.
Roger Bate & Richard Tren | 28 Sep 2005 | Africa Fighting Malaria
Written Testimony of Roger Bate and Richard Tren to the Senate Environment and Public Works Committee hearing on the role of science in environmental policy making.
Richard Tren & Marian L. Tupy | 18 Aug 2005 | Washington Times
Richard Tren and Marian Tupy criticize the European Union for its stance on DDT.
Richard Tren | 22 Jul 2005 | TCS Daily
Richard Tren criticizes the Clinton Foundation for seeking short term solutions to HIV/AIDS.
Roger Bate et al | 06 Jul 2005 | Africa Fighting Malaria
AFM supports the prominence given to malaria and maalria control at the recent World Health Assembly, and encourages the World Health Organization to comply.
Richard Tren | 05 Jul 2005 | Business Day (South Africa)
Richard Tren discusses the role that drug companies will play in long-term AIDS treatment in Africa.
Richard Tren | 01 Jul 2005 | TCS Daily
The innovative drug company Bristol Myers Squibb and its charitable foundation, the Bristol Myers Squibb Foundation have just announced a $40 million program to create a pediatric AIDS treatment corps for Africa.
Roger Bate | 27 Jun 2005 | TCS Daily
Roger Bate discusses Brazil's negotiations with Abbott Laboratories on the price of a new anti-retroviral drug.